Spyre Therapeutics, Inc.
A biotechnology company working to develop next-generation therapeutics for inflammatory bowel disease. Combining novel antibody engineering, rational therapy, and precision immunology approaches, the company develops antibody therapeutics for ulcerative colitis, Crohn's disease, and other conditions. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 30 |
Founded | 2013 |
Financials | |
|---|---|
Market Capitalization | 1.51B |
Revenue | 0.69M |
Operating Income | -271.27M |
Operating Margin | -39428.92% |
Net Income | -364.23M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 5173 / 5373 |
Sector : Healthcare | 1073 / 1144 |
Industry : Biotechnology | 597 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2162 / 5565 |
Sector : Healthcare | 274 / 1182 |
Industry : Biotechnology | 100 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 5250 / 5436 |
Sector : Healthcare | 1119 / 1164 |
Industry : Biotechnology | 635 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4655 / 5330 |
Sector : Healthcare | 894 / 1174 |
Industry : Biotechnology | 443 / 667 |